Suchergebnisse
Suchergebnisse:
Chief Executive Officer. Neil was previously Senior Vice-President, Discovery, at UCB S.A., overseeing an integrated portfolio of small molecule and antibody therapeutic projects in the areas of immunology and neurology. Neil and his teams have been responsible for transitioning 33 new chemical entities into development in immunology, oncology, ...
- Sitryx CEO, Neil Weir, presents at BioEquity Europe 2023
17th May 2023. Sitryx CEO, Neil Weir, presents at BioEquity...
- Sitryx CEO, Neil Weir, presents at BioEquity Europe 2023
Neil Weir (1984–1988) Orchestral Manoeuvres in the Dark ( englisch für: Orchestrale Manöver im Dunkeln ), kurz OMD oder O.M.D., ist eine britische Popband. Sie gehörte in den 1980er Jahren zu den erfolgreichen Vertretern des Synthiepops sowie der New Wave .
Neil Weir. Venture Partner. Neil joined SV as a Venture Partner in 2020. He is Chief Executive Officer of Sitryx Therapeutics, an SV-created company working in the field of immunometabolism to bring novel medicines to unmet needs in inflammation, autoimmunity and immuno-oncology.
Experience: Sitryx · Location: United Kingdom · 500+ connections on LinkedIn. View Neil Weir’s profile on LinkedIn, a professional community of 1 billion members.
- 500+
- Sitryx
- 926
- United Kingdom
Since graduating from Westminster Hospital Medical School in 1965, Mr Neil Weir MD MA FRCS has worked as a consultant otolaryngologist at the Royal Surrey County Hospital, Guildford, and as a neuro-otologist at Atkinson Morley's Hospital in Wimbledon and as a b ioethicist and medical historican.
15. Apr. 2021 · Sitryx Therapeutics Neil Weir biopharmaceutical Iain Kilty immuno-oncology immunometabolism. http://www.sitryx.com. Sitryx further strengthens leadership team with the appointment of Iain...
